Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1989 Apr;61(4):348–355. doi: 10.1136/hrt.61.4.348

Isoprenaline as an aid to the induction of catecholamine dependent supraventricular tachycardias during programmed stimulation.

B Brembilla-Perrot 1, A Terrier de la Chaise 1, M Pichené 1, E Aliot 1, F Cherrier 1, C Pernot 1
PMCID: PMC1216675  PMID: 2713190

Abstract

The effects of isoprenaline on the induction of supraventricular tachycardia by programmed stimulation were studied in 67 patients to see whether they correlated with spontaneous catecholamine mediated symptoms during exercise testing and Holter monitoring. Thirty seven control patients (group 1) did not have spontaneous arrhythmias either during exercise testing or Holter monitoring. Thirty patients (group 2) had documented exercise or stress related supraventricular tachycardias--that is paroxysmal junctional tachycardia (24) or atrial arrhythmia (6). Programmed electrical stimulation was performed before and during the infusion of isoprenaline. No group 1 patient developed sustained supraventricular tachycardia during isoprenaline infusion. In 21 patients with paroxysmal junctional tachycardia and all the patients with atrial arrhythmias electrical stimulation during isoprenaline infusion produced the same tachycardia that had been seen during exercise testing and Holter monitoring. Changes in electrophysiological variables and the concentrations of serum potassium were not associated with the induction of supraventricular tachycardia by isoprenaline. Infusion of isoprenaline safely facilitated the induction of supraventricular tachycardia by programmed stimulation in patients who had spontaneously occurring catecholamine mediated symptoms.

Full text

PDF
348

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnold J. M., McDevitt D. G. Contribution of the vagus to the haemodynamic responses following intravenous boluses of isoprenaline. Br J Clin Pharmacol. 1983 Apr;15(4):423–429. doi: 10.1111/j.1365-2125.1983.tb01525.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brembilla-Perrot B., Terrier de la Chaise A., Pichène M., Pernot C., Cherrier F. Valeur diagnostique du test à l'Isuprel dans les tachycardies d'effort. Arch Mal Coeur Vaiss. 1986 Mar;79(3):302–313. [PubMed] [Google Scholar]
  3. Brugada P., Facchini M., Wellens H. J. Effects of isoproterenol and amiodarone and the role of exercise in initiation of circus movement tachycardia in the accessory atrioventricular pathway. Am J Cardiol. 1986 Jan 1;57(1):146–149. doi: 10.1016/0002-9149(86)90969-0. [DOI] [PubMed] [Google Scholar]
  4. Coumel P., Attuel P., Leclercq J. F., Friocourt P. Arythmies auriculaires d'origine vagale ou catécholergique. Effets comparés du traitement bêta-bloquant et phènomène d'èchappement. Arch Mal Coeur Vaiss. 1982 Apr;75(4):373–387. [PubMed] [Google Scholar]
  5. Dimsdale J. E., Hartley L. H., Guiney T., Ruskin J. N., Greenblatt D. Postexercise peril. Plasma catecholamines and exercise. JAMA. 1984 Feb 3;251(5):630–632. doi: 10.1001/jama.251.5.630. [DOI] [PubMed] [Google Scholar]
  6. Freedman R. A., Swerdlow C. D., Echt D. S., Winkle R. A., Soderholm-Difatte V., Mason J. W. Facilitation of ventricular tachyarrhythmia induction by isoproterenol. Am J Cardiol. 1984 Oct 1;54(7):765–770. doi: 10.1016/s0002-9149(84)80205-2. [DOI] [PubMed] [Google Scholar]
  7. Gamble W. H., Shaver J. A., Alvares R. F., Salerni R., Reddy P. S. A critical appraisal of diastolic time intervals as a measure of relaxation in left ventricular hypertrophy. Circulation. 1983 Jul;68(1):76–87. doi: 10.1161/01.cir.68.1.76. [DOI] [PubMed] [Google Scholar]
  8. Gettes L. S., Surawicz B. Long-term prevention of paroxysmal arrhythmias with propranolol therapy. Am J Med Sci. 1967 Sep;254(3):257–265. [PubMed] [Google Scholar]
  9. Hariman R. J., Gomes J. A., El-Sherif N. Catecholamine-dependent atrioventricular nodal reentrant tachycardia. Circulation. 1983 Mar;67(3):681–686. doi: 10.1161/01.cir.67.3.681. [DOI] [PubMed] [Google Scholar]
  10. Kassebaum D. G., Van Dyke A. R. Electrophysiological effects of isoproterenol on Purkinje fibers of the heart. Circ Res. 1966 Nov;19(5):940–946. doi: 10.1161/01.res.19.5.940. [DOI] [PubMed] [Google Scholar]
  11. Krikler D., Curry P., Attuel P., Coumel P. 'Incessant' tachycardias in Wolff-Parkinson-White syndrome. I: Initiation without antecedent extrasystoles or PR lengthening, with reference to reciprocation after shortening of cycle length. Br Heart J. 1976 Sep;38(9):885–896. doi: 10.1136/hrt.38.9.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lévy S., Broustet J. P., Clémenty J., Vircoulon B., Guern P., Bricaud H. Syndrome de Wolff-Parkinson-White. Corrélations entre l'exploration électrophysiologique et l'effet de l'épreuve d'effort sur l'aspect électrocardiographique de préexcitation. Arch Mal Coeur Vaiss. 1979 Jun;72(6):634–640. [PubMed] [Google Scholar]
  13. Lévy S., Pierron J. P., Eisinger J. F., Franchi J., Faugère G., Valeix B., Marion J., Gérard R. Tachycardie supraventriculaire induite par l'effort et les catécholamines. Arch Mal Coeur Vaiss. 1985 Sep;78(9):1431–1436. [PubMed] [Google Scholar]
  14. Reddy C. P., Gettes L. S. Use of isoproterenol as an aid to electric induction of chronic recurrent ventricular tachycardia. Am J Cardiol. 1979 Oct;44(4):705–713. doi: 10.1016/0002-9149(79)90291-1. [DOI] [PubMed] [Google Scholar]
  15. Strasberg B., Ashley W. W., Wyndham C. R., Bauernfeind R. A., Swiryn S. P., Dhingra R. C., Rosen K. M. Treadmill exercise testing in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1980 Apr;45(4):742–748. doi: 10.1016/0002-9149(80)90116-2. [DOI] [PubMed] [Google Scholar]
  16. Struthers A. D., Reid J. L., Whitesmith R., Rodger J. C. Effect of intravenous adrenaline on electrocardiogram, blood pressure, and serum potassium. Br Heart J. 1983 Jan;49(1):90–93. doi: 10.1136/hrt.49.1.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Vargas G., Akhtar M., Damato A. N. Electrophysiologic effects of isoproterenol on cardiac conduction system in man. Am Heart J. 1975 Jul;90(1):25–34. doi: 10.1016/0002-8703(75)90253-7. [DOI] [PubMed] [Google Scholar]
  18. Wellens H. J., Brugada P., Roy D., Weiss J., Bär F. W. Effect of isoproterenol on the anterograde refractory period of the accessory pathway in patients with the Wolff-Parkinson-White syndrome. Am J Cardiol. 1982 Jul;50(1):180–184. doi: 10.1016/0002-9149(82)90026-1. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES